Aardvark Therapeutics, Inc. Common Stock
Status: Publicly traded
Direct answer
Aardvark Therapeutics, Inc. Common Stock is publicly traded on NASDAQ under the ticker AARD.
Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's natural regulatory systems (innate homeostatic pathways) to combat metabolic disorders. The company's primary experimental drug, ARD-101, is an orally administered, gut-specific small molecule. It functions as an...
Can you invest in Aardvark Therapeutics, Inc. Common Stock?
Yes. Aardvark Therapeutics, Inc. Common Stock is publicly traded on NASDAQ under the ticker AARD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Aardvark Therapeutics, Inc. Common Stock
Detailed equity research is provided by MarketSnap.